USCB Financial Holdings (USCB) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
21 Apr, 2026Executive summary
The 2026 annual meeting will be held virtually on May 26, 2026, with shareholders able to vote and ask questions online.
Shareholders of record as of April 6, 2026, are entitled to vote on the election of directors and ratification of the external auditor.
The Board recommends voting for all director nominees and for the ratification of Crowe LLP as the independent auditor for 2026.
Proxy materials are available online, and multiple voting methods are provided, including online, phone, and mail.
Voting matters and shareholder proposals
Shareholders will vote on electing nine directors for a one-year term expiring in 2027.
Ratification of Crowe LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, is on the agenda.
No other business is expected, and no shareholder proposals or nominations were received for this meeting.
Shareholder proposals for the 2027 meeting must be received by December 22, 2026.
Board of directors and corporate governance
The Board consists of nine nominees, with a mix of experienced professionals in law, banking, finance, healthcare, and marketing.
All directors except the CEO are considered independent under Nasdaq rules.
The Board combines the roles of Chairperson and CEO, with a lead independent director to balance governance.
Standing committees include audit and risk, compensation, and nominating and corporate governance, all with independent members.
Directors receive an annual retainer of $110,000, with additional fees for committee chairs; compensation can be paid in restricted stock.
Latest events from USCB Financial Holdings
- Record Q1 2026 earnings with 33% EPS growth, double-digit loan and deposit gains.USCB
Q1 202624 Apr 2026 - Operating EPS was $0.44, with strong growth and a 25% dividend increase despite restructuring.USCB
Q4 202511 Apr 2026 - Q2 net income up 48% to $6.2M, with record EPS, strong loan growth, and robust asset quality.USCB
Q2 20242 Feb 2026 - Net income up 82% to $6.9M, with record EPS, strong growth, and improved efficiency.USCB
Q3 202417 Jan 2026 - EPS more than doubled, net income surged, and dividend was doubled amid strong growth.USCB
Q4 20249 Jan 2026 - Registering $100M in securities and 9M shares for sale, supporting growth and investor liquidity.USCB
Registration Filing16 Dec 2025 - Shareholders will vote virtually on director elections and auditor ratification, with strong governance and oversight.USCB
Proxy Filing2 Dec 2025 - Q1 2025 net income up 66% with strong loan/deposit growth and a $0.10 dividend declared.USCB
Q1 202529 Nov 2025 - Q2 net income up 31% year-over-year, driven by loan growth, margin expansion, and strong asset quality.USCB
Q2 202516 Nov 2025